3rd Quarter - Report

MASIMO CORPORATION for MASIMO CORPORATION

Firm
Client
Income
—
Expenses
$130,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Support for monitoring of patients taking opioids, education for patients, providers, caregivers and the public on the dangers of opioids, and patient safety in general; Support for adequate coverage and reimbursement in Medicare coverage and reimbursement for medical devices; Support of legislation to mandate continuous monitoring for patients taking opioids; Support for policies and legislation to alleviate healthcare worker burnout with the use of medical technology; Patient safety policy and legislation; Remote patient monitoring technology Medicare coverage; Support for Medicare coverage and reimbursement pathway for breakthrough technologies (TCET)

LobbyistCovered position, as disclosed
CATHERINE MEIER —
PAUL ORDAL —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Copyright/Patent/Trademark CPT

Issues related to intellectual property and anti-competitive behavior in the medical device supply chain; International Trade Commission

LobbyistCovered position, as disclosed
CATHERINE MEIER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.